This website uses cookies to enhance the user experience.
||
HORIZON THERAPEUTICS NORWAY AS

HORIZON THERAPEUTICS NORWAY AS929 107 209

Marketing
Limited company
Wergelandsveien 7 0167 OSLO, Norge

HORIZON THERAPEUTICS NORWAY AS

Closed at March 21st, 2025, Voluntary liquidation
Horizon Therapeutics
Horizon Therapeutics is a biotechnology company that is driven to deliver breakthrough medicines to patients because we understand the challenges they face.
Tilby, til fordel for andre selskaper i samme konsern, rådgivning, hjelp, markedsføring og støtte, samt å ha en administrativ, teknisk eller forretningsmessig rolle i tilknytning til legemidler og relaterte produkter, drive markedsføring av konsernets varemerkekatalog, i tillegg til å tilby tjenester til selgere av og agenter som selger slike produkter.
Rådgivning, hjelp, markedsføring og støtte, samt å ha en administrativ, teknisk eller forretningsmessig rolle i tilknytning til legemidler og relaterte produkter, drive markedsføring av konsernets varemerkekatalog, i tillegg til å tilby tjenester til selgere av og agenter som selger slike produkter.

Keywords

advertising businesscreative businessproductionadvertising materialarrangementimplementationadvertising campaignsdesignplacementadvertisementsnewspapersmagazinesradio and televisioninternetoutdoor advertisingbillboardsposterswindow displayinterior designshowroomscarsbusesaerial advertisingdistributiondeliverypromotional materialsamplesprocurementracksmarketing campaignsmarketing consultancy

Links

Organization

Chairman of the board
Operation time
3 years
- Apr 27, 2022 to Mar 21, 2025
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person

Financials

Total equity 2024
30,000
NOK
Last update: Feb 4, 2025

Management

Board

NameRoleShares
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
K
KPMG ACCOUNTING AS
Accountant-
Last update: Jun 1, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202420232022
Total operating income
0
0
0
Annual Total Result
0
0
0
Total assets
30,000
30,000
30,000
Total liabilities
0
0
0
Total equity
30,000
30,000
30,000

P&L

Year202420232022
Total operating income
0
0
0
Total operating costs
0
0
0
Operating result
0
0
0
Financial income/costs
0
0
0
Profit before tax
0
0
0
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
0
0
0

Balance overview

Year202420232022
Total fixed assets
0
0
0
Total current assets
30,000
30,000
30,000
Total assets
30,000
30,000
30,000
Short term debt
0
0
0
Long term debt
0
0
0
Total liabilities
0
0
0
Contributed capital
30,000
30,000
30,000
Retained earnings
0
0
0
Total equity
30,000
30,000
30,000
Total equity and liabilities
30,000
30,000
30,000

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
73
Activity
Advertising and market research
73.1
Main industrial group
Advertising
73.11
Industrial group
Advertising agencies
73.110
Industrial group
Advertising agencies